DMC is unleashing the manufacturing power of biology. The company is democratizing metabolic engineering and bioprocess development to accelerate commercial deployment of sustainable bio-based products across multiple markets. The company's lead product family will provide ingredients for the animal and human nutrition markets. In addition, pipeline product families in development by DMC will address unmet customer needs in sectors that include specialty chemicals, flavors and fragrances, and personal care.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/11/19 | $10,300,000 | Series A |
Breakthrough Energy Ventures Capricorn Venture Partners Sofinnova Partners  | undisclosed |
